Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation von Tremaroli, Valentina, Karlsson, Fredrik, Werling, Malin, Ståhlman, Marcus, Kovatcheva-Datchary, Petia, Olbers, Torsten, Fändriks, Lars, le Roux, Carel W., Nielsen, Jens, Bäckhed, Fredrik

Volltext

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management von Pi-Sunyer, Xavier, Astrup, Arne, Fujioka, Ken, Greenway, Frank, Halpern, Alfredo, Krempf, Michel, Lau, David C.W, le Roux, Carel W, Violante Ortiz, Rafael, Jensen, Christine Bjørn, Wilding, John P.H

Volltext

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update von Jakubowska, Agnieszka, Roux, Carel W le, Viljoen, Adie

Volltext

Amylin as a Future Obesity Treatment von Dehestani, Babak, Stratford, Nicholas Rs, le Roux, Carel W

Volltext

Weight Loss, Satiety, and the Postprandial Gut Hormone Response After Esophagectomy: A Prospective Study von Elliott, Jessie A, Docherty, Neil G, Eckhardt, Hans-Georg, Doyle, Suzanne L, Guinan, Emer M, Ravi, Narayanasamy, Reynolds, John V, Roux, Carel W le

Volltext

Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty von Werling, Malin, Olbers, Torsten, Fändriks, Lars, Bueter, Marco, Lönroth, Hans, Stenlöf, Kaj, le Roux, Carel W

Volltext

Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus von Docherty, Neil G., le Roux, Carel W.

Volltext

Mechanisms of Weight Loss After Obesity Surgery von Akalestou, Elina, Miras, Alexander D, Rutter, Guy A, le Roux, Carel W

Volltext

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters von LE ROUX, Carel W, AYLWIN, Simon J. B, BATTERHAM, Rachel L, BORG, Cynthia M, COYLE, Frances, PRASAD, Vyas, SHUREY, Sandra, GHATEI, Mohammad A, PATEL, Ameet G, BLOOM, Stephen R

Volltext

Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery? von Papamargaritis, Dimitris, le Roux, Carel W

Volltext

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes von Riddle, Matthew C, Cefalu, William T, Evans, Philip H, Gerstein, Hertzel C, Nauck, Michael A, Oh, William K, Rothberg, Amy E, le Roux, Carel W, Rubino, Francesco, Schauer, Philip, Taylor, Roy, Twenefour, Douglas

Volltext

Ciliary neurotrophic factor is increased in the plasma of patients with obesity and its levels correlate with diabetes and inflammation indices von Perugini, Jessica, Di Mercurio, Eleonora, Giuliani, Angelica, Sabbatinelli, Jacopo, Bonfigli, Anna Rita, Tortato, Elena, Severi, Ilenia, Cinti, Saverio, Olivieri, Fabiola, le Roux, Carel W., Gesuita, Rosaria, Giordano, Antonio

Volltext

Roux-en-Y Gastric Bypass Surgery Increases Respiratory Quotient and Energy Expenditure during Food Intake von Werling, Malin, Fändriks, Lars, Olbers, Torsten, Bueter, Marco, Sjöström, Lars, Lönroth, Hans, Wallenius, Ville, Stenlöf, Kaj, le Roux, Carel W

Volltext

New therapies for obesity von Papamargaritis, Dimitris, le Roux, Carel W, Holst, Jens J, Davies, Melanie J

Volltext

Obesity in adults von Lingvay, Ildiko, Cohen, Ricardo V, Roux, Carel W le, Sumithran, Priya

Volltext

COVID-19 alters thinking and management in metabolic diseases von le Roux, Carel W.

Volltext

Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer von Sinclair, Piriyah, Brennan, Donal J., le Roux, Carel W.

Volltext

Obesity: A critical risk factor in the COVID‐19 pandemic von Kwok, See, Adam, Safwaan, Ho, Jan Hoong, Iqbal, Zohaib, Turkington, Peter, Razvi, Salman, Le Roux, Carel W., Soran, Handrean, Syed, Akheel A.

Volltext

Bariatric surgery for type 2 diabetes von Dixon, John B, Prof, le Roux, Carel W, MRCP, Rubino, Francesco, MD, Zimmet, Paul, Prof

Volltext

Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial von le Roux, Carel W, Steen, Oren, Lucas, Kathryn J, Startseva, Elena, Unseld, Anna, Hennige, Anita M

Volltext